Previous 10 | Next 10 |
2023-10-27 06:13:05 ET More on Avantor Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade) Avantor Q3 2023 Earnings Preview Eminence Capital adds Dave & Buster's, exits Vertiv Holdings in Q2 Seeking Alpha’s Qu...
Avantor® Reports Third Quarter 2023 Results PR Newswire Net sales of $1.72 billion , decrease of 7.3%; core organic decline of 7.9% Net income of $108.4 million ; Adjusted EBITDA of $317.8 million Diluted GAAP EPS of $0.16 ; adjusted EPS of $0.25...
Avantor Inc. (AVTR) is expected to report $0.25 for Q3 2023
2023-10-26 13:12:49 ET More on Avantor Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade) Avantor, Inc. (AVTR) Q2 2023 Earnings Call Transcript Eminence Capital adds Dave & Buster's, exits Vertiv Holdings in Q2 Seek...
Responding to new expectations demands a robust governance framework to address environmental, social, and political issues WALTHAM, MA / ACCESSWIRE / October 25, 2023 / Leaders of global corporations and financial institutions are facing heightened expectations to play a role in addressing ...
2023-10-01 16:02:12 ET Bernstein is bullish on medtech stocks Thermo Fisher, Guardant Health, Revvity and PacBio, but sees further downside for Illumina, according to a new industry note. The investment firm kicked off coverage of the US life science tools and diagnostics sector last we...
Avantor® to Host Third Quarter 2023 Earnings Call on Friday, October 27, 2023 PR Newswire RADNOR, Pa. , Sept. 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sc...
Avantor® Announces Ger Brophy to Retire in 2024; Benoit Gourdier Appointed EVP, Biopharma Production PR Newswire RADNOR, Pa. , Sept. 26, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to c...
Avantor® Announces New Scientific Advisory Board PR Newswire Board Will Accelerate Solutions for Life Sciences Customers; Includes Experts in Biologic Manufacturing Sciences and Technology, Chemistry and Gene Therapy RADNOR, Pa. , Sept. 21, 2023 /PRNewsw...
2023-09-20 05:21:58 ET More on the markets No Signs Of A Major Top Yet, Staying Long XYLD: The S&P 500 Is Begging You To Consider Covered Call ETFs, But JEPI Is Not The Only Game In Town Stick A Fork In The Fed Buffett Yardstick And 4 More Indicators Sign...
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for AVTR on July 2, 2024 07:56AM ET. The previous analyst recommendation was Outperform. AVTR was trading at $20.77 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease PR Newswire Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Av...
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024 PR Newswire RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life scien...